Tarek Ali Zaki, Gastón Soria, Candelaria Llorens de los Ríos, Gerardo Gatti
Company Description
OncoPrecision has developed a Patient Micro Avatar (PMA) technology to accurately recreate cancer patients’ disease for ex-vivo therapy screening to reduce the trial-and-error in cancer treatment at the clinic and increase the success of oncology drug development.